This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Biolexis Therapeutics, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Dongqing Yan: Innovator in Pharmaceutical Chemistry
Introduction
Dongqing Yan is a notable inventor based in Lehi, UT (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of CDK9 inhibitors. His work focuses on innovative compounds that have potential therapeutic applications.
Latest Patents
Dongqing Yan holds a patent for CDK9 inhibitors, which includes a stereoisomer or salt, such as a pharmaceutically acceptable salt. The patent outlines the use of these compounds as components of pharmaceutical compositions and methods for their application in medical treatments.
Career Highlights
Currently, Dongqing Yan is associated with Biolexis Therapeutics, Inc., where he continues to advance his research and development efforts. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in the industry.
Collaborations
Dongqing Yan has collaborated with notable colleagues, including Hariprasad Vankayalapati and Zhaoliang Li. These partnerships have fostered innovation and contributed to the success of their projects.
Conclusion
Dongqing Yan's work in developing CDK9 inhibitors exemplifies his commitment to advancing pharmaceutical science. His contributions are paving the way for new therapeutic options in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile